Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07047456
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Who this might be right for
Acute Graft Versus Host Disease
Anhui Provincial Hospital 134
Early research (Phase 1)UnknownNCT05352269
What this trial is testing

Safety and Tolerability of FMT Capsules in Healthy Volunteers

Who this might be right for
Acute-graft-versus-host Disease
Shenzhen Xbiome Biotech Co., Ltd. 36
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Ended earlyNCT03805789
What this trial is testing

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

Who this might be right for
Acute-graft-versus-host Disease
CSL Behring 222
Testing effectiveness (Phase 2)Ended earlyNCT04269850
What this trial is testing

Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

Who this might be right for
Intestinal GVHD
St. Petersburg State Pavlov Medical University 2
Testing effectiveness (Phase 2)Looking for participantsNCT05436418
What this trial is testing

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Who this might be right for
Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 260
Testing effectiveness (Phase 2)Study completedNCT02806947
What this trial is testing

Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Who this might be right for
Acute GVHD
Medical College of Wisconsin 127
Testing effectiveness (Phase 2)Ended earlyNCT02619617
What this trial is testing

Safety and Efficacy Study of SOM230 s.c. in Cluster Headache

Who this might be right for
Cluster Headache - Episodic and Chronic
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Looking for participantsNCT07340723
What this trial is testing

Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )

Who this might be right for
GVHD,AcuteStem Cell Transplant Complications
Daihong Liu 168
Testing effectiveness (Phase 2)Study completedNCT03846479
What this trial is testing

Itacitinib for Low Risk GVHD

Who this might be right for
Low Risk Acute Graft-versus-host DiseaseGraft-versus-host-diseaseGVHD
John Levine 70
Not applicableStudy completedNCT00579397
What this trial is testing

Markers of Inflammation in Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host Disease
Ann & Robert H Lurie Children's Hospital of Chicago 30
Not applicableNo Longer AvailableNCT01200017
What this trial is testing

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more
Christopher Dvorak
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)WithdrawnNCT01616680
What this trial is testing

Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Early research (Phase 1)Ended earlyNCT04006652
What this trial is testing

ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

Who this might be right for
Acute Graft Versus Host DiseaseHaploidentical Hematopoietic Stem Cell Transplant
Washington University School of Medicine 4
Testing effectiveness (Phase 2)Ended earlyNCT04941404
What this trial is testing

TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Glucocorticoid-Refractory aGVHD
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 13
Not applicableStudy completedNCT04674917
What this trial is testing

Effects of Decompression in Patient With Acute vs Chronic Lumbar Radiculopathy

Who this might be right for
Lumbar Radiculopathy
Riphah International University 30
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Ended earlyNCT03963024
What this trial is testing

Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

Who this might be right for
Irradiated Bone MarrowTransplant-Related Hematologic MalignancyLeukemia, Acute+2 more
IRCCS San Raffaele 9
Next Page